Clinical Trial Update: Pomalidomide for Kaposi Sarcoma in People With or Without HIV [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pomalidomide for Kaposi sarcoma; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposis Sarcoma
• Sarcoma Kaposi

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kaposi Sarcoma, Sarcoma, Kaposi | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-11-01